Published on Tuesday October 06, 2020

Smooth Drug Development September 2020 News Release

We were working on the following new projects in September:

  • Observational trial is being initiated in dermatology.
  • We signed a contract for a bioequivalence study (INN: Paracetamol) with long-term sponsor.
  • Several contracts with international sponsors for PV services were signed.

Clinical Department News

  • Few projects restarted after COVID-19 pandemic.
  • Enrollment finished in phase III trial in arthrosis.
  • We are preparing for submission in III phase trial in COVID-19.
  • We did a lot of work in II phase trial in COVID-19: contracts with sites are signing, LEC approvals from first site were received, eCRF development was finished and we are preparing protocol amendment.